Browsing Tag
Gan & Lee Pharmaceuticals Co.
1 post
Gan & Lee Pharmaceuticals doses first participant with once-weekly oral GLP-1 candidate
Gan & Lee Pharmaceuticals has dosed the first participant in a 112-person Phase I study of GZC8072, an oral peptide GLP-1 receptor agonist designed for once-weekly administration, putting pharmacokinetics and tolerability ahead of any near-term weight-loss claims.